TY - STD TI - WHO. Global tuberculosis report 2020. WHO/HTM/TB/202011 2020. (https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf) UR - https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf ID - ref1 ER - TY - STD TI - Compendium of TB/COVID-19 studies. Geneva: World Health Organization; 2020 (https://www.who.int/ teams/global-tuberculosis-programme/covid-19/compendium, accessed 29 July 2020). UR - https://www.who.int/ ID - ref2 ER - TY - STD TI - Digital health for the End TB Strategy: an agenda for action (WHO/HTM/TB/2015.21). Geneva: WHO; 2015 (https://www.who.int/tb/publications/digitalhealth-TB-agenda/en/, accessed 29 July 2020). UR - https://www.who.int/tb/publications/digitalhealth-TB-agenda/en/ ID - ref3 ER - TY - JOUR AU - Pang, Y. AU - Lu, J. AU - Huo, F. AU - Ma, Y. AU - Zhao, L. AU - Li, Y. AU - Liang, Q. AU - Chu, N. AU - Gao, M. AU - Huang, H. PY - 2017 DA - 2017// TI - Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: A five-year review JO - J Infect VL - 75 UR - https://doi.org/10.1016/j.jinf.2017.08.005 DO - 10.1016/j.jinf.2017.08.005 ID - Pang2017 ER - TY - JOUR AU - Wu, B. AU - Zhang, L. AU - Liu, Z. AU - He, H. AU - Pan, A. AU - Wang, F. AU - Zhang, M. AU - Chen, B. AU - Lu, Z. AU - Chen, S. AU - Wang, X. PY - 2017 DA - 2017// TI - Drug-resistant tuberculosis in Zhejiang Province, China: an updated analysis of time trends, 1999–2013 JO - Glob Health Action VL - 10 UR - https://doi.org/10.1080/16549716.2017.1293925 DO - 10.1080/16549716.2017.1293925 ID - Wu2017 ER - TY - JOUR AU - Nunn, A. J. AU - Rusen, I. D. AU - Deun, A. AU - Torrea, G. AU - Phillips, P. P. AU - Chiang, C. Y. AU - Squire, S. B. AU - Madan, J. AU - Meredith, S. K. PY - 2014 DA - 2014// TI - Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial JO - Trials VL - 15 UR - https://doi.org/10.1186/1745-6215-15-353 DO - 10.1186/1745-6215-15-353 ID - Nunn2014 ER - TY - JOUR AU - Farley, J. E. AU - Ram, M. AU - Pan, W. AU - Waldman, S. AU - Cassell, G. H. AU - Chaisson, R. E. AU - Weyer, K. AU - Lancaster, J. AU - Walt, M. PY - 2011 DA - 2011// TI - Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence JO - PLoS ONE VL - 6 UR - https://doi.org/10.1371/journal.pone.0020436 DO - 10.1371/journal.pone.0020436 ID - Farley2011 ER - TY - STD TI - WHO. Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis, Geneva, 2014. ID - ref8 ER - TY - JOUR AU - Liu, Q. AU - Yang, D. AU - Qiu, B. AU - Martinez, L. AU - Ji, Y. AU - Song, H. AU - Li, Z. AU - Wang, J. PY - 2021 DA - 2021// TI - Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China JO - PLoS Negl Trop Dis VL - 15 UR - https://doi.org/10.1371/journal.pntd.0009068 DO - 10.1371/journal.pntd.0009068 ID - Liu2021 ER - TY - JOUR AU - Tang, S. AU - Tan, S. AU - Yao, L. AU - Li, F. AU - Li, L. AU - Guo, X. AU - Liu, Y. AU - Hao, X. AU - Li, Y. AU - Ding, X. AU - Zhang, Z. AU - Tong, L. AU - Huang, J. PY - 2013 DA - 2013// TI - Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0082943 DO - 10.1371/journal.pone.0082943 ID - Tang2013 ER - TY - JOUR AU - Piparva, K. G. AU - Jansari, G. AU - Singh, A. P. PY - 2018 DA - 2018// TI - Evaluation of treatment outcome and adverse drug reaction of directly observed treatment (DOT) plus regimen in multidrug-resistant tuberculosis (MDR-TB) patients at district tuberculosis centre Rajkot JO - Perspect Clin Res VL - 9 ID - Piparva2018 ER - TY - STD TI - Dela AI , Tank NKD, Singh AP, Piparva KG. Adverse drug reactions and treatment outcome analysis of DOTS-plus therapy of MDR-TB patients at district tuberculosis centre: A four year retrospective study, Lung India : official organ of Indian Chest Society. 34 (2017) 522–526.13. ID - ref12 ER - TY - JOUR AU - Patel, S. V. AU - Nimavat, K. B. AU - Alpesh, P. B. AU - Shukla, L. K. AU - Shringarpure, K. S. AU - Mehta, K. G. AU - Joshi, C. C. PY - 2016 DA - 2016// TI - Treatment outcome among cases of multidrug-resistant tuberculosis (MDR TB) in Western India: A prospective study JO - J Infect Public Health VL - 9 UR - https://doi.org/10.1016/j.jiph.2015.11.011 DO - 10.1016/j.jiph.2015.11.011 ID - Patel2016 ER - TY - JOUR AU - Hassane-Harouna, S. AU - Cherif, G. F. AU - Ortuno-Gutierrez, N. AU - Cisse, D. AU - Camara, L. M. AU - Diallo, B. D. AU - Camara, S. AU - Bangoura, A. M. AU - Lynen, L. AU - Decroo, T. PY - 2020 DA - 2020// TI - Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study JO - PLoS ONE VL - 15 UR - https://doi.org/10.1371/journal.pone.0237355 DO - 10.1371/journal.pone.0237355 ID - Hassane-Harouna2020 ER - TY - JOUR AU - Bhering, M. AU - Duarte, R. AU - Kritski, A. PY - 2019 DA - 2019// TI - Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000–2016 JO - PLoS ONE VL - 14 UR - https://doi.org/10.1371/journal.pone.0218299 DO - 10.1371/journal.pone.0218299 ID - Bhering2019 ER - TY - STD TI - Gao M, Gao J, Xie L, Wu G, Chen W, Chen Y, Pei Y, Li G, Liu Y, Shu W, Fan L, Wu Q, Du J, Chen X, Tang P, Xiong Y, Li M, Cai Q, Jin L, Mei Z, Pang Y, Li L, Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, (2020). ID - ref16 ER - TY - STD TI - Mok J, Kang H, Koh WJ, Jhun BW, Yim JJ, Kwak N, Lee T, Kang B, Jeon D. Final treatment outcomes of delamanid-containing regimens in patients with MDR-/XDR-TB in South Korea, The European respiratory journal, 54 (2019). ID - ref17 ER - TY - STD TI - S.E. Borisov, K. Dheda, M. Enwerem, R. Romero Leyet, L. D'Ambrosio, R. Centis, G. Sotgiu, S. Tiberi, J.W. Alffenaar, A. Maryandyshev, E. Belilovski, S. Ganatra, A. Skrahina, O. Akkerman, A. Aleksa, R. Amale, J. Artsukevich, J. Bruchfeld, J.A. Caminero, I. Carpena Martinez, L. Codecasa, M. Dalcolmo, J. Denholm, P. Douglas, R. Duarte, A. Esmail, M. Fadul, A. Filippov, L. Davies Forsman, M. Gaga, J.A. Garcia-Fuertes, J.M. Garcia-Garcia, G. Gualano, J. Jonsson, H. Kunst, J.S. Lau, B. Lazaro Mastrapa, J.L. Teran Troya, S. Manga, K. Manika, P. Gonzalez Montaner, J. Mullerpattan, S. Oelofse, M. Ortelli, D.J. Palmero, F. Palmieri, A. Papalia, A. Papavasileiou, M.C. Payen, E. Pontali, C. Robalo Cordeiro, L. Saderi, T.D. Sadutshang, T. Sanukevich, V. Solodovnikova, A. Spanevello, S. Topgyal, F. Toscanini, A.R. Tramontana, Z.F. Udwadia, P. Viggiani, V. White, A. Zumla, G.B. Migliori, Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study, The European respiratory journal, 49 (2017). ID - ref18 ER - TY - JOUR AU - Farley, J. E. AU - Ram, M. AU - Pan, W. PY - 2011 DA - 2011// TI - Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence JO - PLoS ONE VL - 6 UR - https://doi.org/10.1371/journal.pone.0020436 DO - 10.1371/journal.pone.0020436 ID - Farley2011 ER - TY - JOUR AU - Jacobson, K. R. AU - Tierney, D. B. AU - Jeon, C. Y. AU - Mitnick, C. D. AU - Murray, M. B. PY - 2010 DA - 2010// TI - Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis JO - Clin Infect Dis VL - 51 UR - https://doi.org/10.1086/653115 DO - 10.1086/653115 ID - Jacobson2010 ER - TY - JOUR AU - Chen, S. AU - Huai, P. AU - Wang, X. PY - 2013 DA - 2013// TI - Risk factors for multidrug resistance among previously treated patients with tuberculosis in eastern China: a case-control study JO - Int J Infect Dis VL - 17 UR - https://doi.org/10.1016/j.ijid.2013.06.006 DO - 10.1016/j.ijid.2013.06.006 ID - Chen2013 ER - TY - JOUR AU - Lee, M. AU - Mok, J. AU - Kim, D. K. AU - Shim, T. S. AU - Koh, W. J. AU - Jeon, D. AU - Lee, T. AU - Lee, S. H. AU - Kim, J. S. AU - Park, J. S. AU - Lee, J. Y. AU - Kim, S. Y. AU - Lee, J. H. AU - Jo, K. W. AU - Jhun, B. W. AU - Kang, Y. A. AU - Ahn, J. H. AU - Kim, C. K. AU - Shin, S. AU - Song, T. AU - Shin, S. J. AU - Kim, Y. R. AU - Ahn, H. AU - Hahn, S. AU - Won, H. J. AU - Jang, J. Y. AU - Cho, S. N. AU - Yim, J. J. PY - 2019 DA - 2019// TI - Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial JO - Trials VL - 20 UR - https://doi.org/10.1186/s13063-018-3053-1 DO - 10.1186/s13063-018-3053-1 ID - Lee2019 ER - TY - JOUR AU - Harouna, S. H. AU - Ortuno-Gutierrez, N. AU - Souleymane, M. B. AU - Kizito, W. AU - Morou, S. AU - Boukary, I. AU - Zolfo, M. AU - Benedetti, G. AU - Piubello, A. PY - 2019 DA - 2019// TI - Short-course treatment outcomes and adverse events in adults and children-adolescents with MDR-TB in Niger JO - Int J Tuberculosis Lung Dis VL - 23 UR - https://doi.org/10.5588/ijtld.17.0871 DO - 10.5588/ijtld.17.0871 ID - Harouna2019 ER - TY - JOUR AU - Tabarsi, P. AU - Chitsaz, E. AU - Baghaei, P. PY - 2010 DA - 2010// TI - Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran JO - Microb Drug Resist VL - 16 UR - https://doi.org/10.1089/mdr.2009.0073 DO - 10.1089/mdr.2009.0073 ID - Tabarsi2010 ER - TY - JOUR AU - Matsui, T. AU - Pinhata, J. M. W. AU - Rabello, M. AU - Brandao, A. P. AU - Ferrazoli, L. AU - Leao, S. C. AU - Viana-Niero, C. AU - Oliveira, R. S. PY - 2020 DA - 2020// TI - Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from Sao Paulo JO - Brazil, Memorias do Instituto Oswaldo Cruz VL - 115 UR - https://doi.org/10.1590/0074-02760200055 DO - 10.1590/0074-02760200055 ID - Matsui2020 ER - TY - JOUR AU - Sayadi, M. AU - Zare, H. AU - Jamedar, S. A. AU - Hashemy, S. I. AU - Meshkat, Z. AU - Soleimanpour, S. AU - Hoffner, S. AU - Ghazvini, K. PY - 2020 DA - 2020// TI - Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran JO - BMC Infect Dis VL - 20 UR - https://doi.org/10.1186/s12879-020-05112-5 DO - 10.1186/s12879-020-05112-5 ID - Sayadi2020 ER - TY - JOUR AU - Walt, M. AU - Lancaster, J. AU - Odendaal, R. AU - Davis, J. G. AU - Shean, K. AU - Farley, J. PY - 2013 DA - 2013// TI - Serious treatment related adverse drug reactions amongst anti-retroviral naive MDR-TB patients JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0058817 DO - 10.1371/journal.pone.0058817 ID - Walt2013 ER - TY - JOUR AU - Marais, E. AU - Mlambo, C. K. AU - Lewis, J. J. PY - 2014 DA - 2014// TI - Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng JO - South Africa Infection VL - 42 ID - Marais2014 ER - TY - JOUR AU - Mishra, B. AU - Rockey, S. M. AU - Gupta, S. AU - Srinivasa, H. AU - Muralidharan, S. PY - 2012 DA - 2012// TI - Multi-drug-resistant tuberculosis: the experience of an urban tertiary care hospital in South India using automated BACTEC 460 TB JO - Trop Doct VL - 42 UR - https://doi.org/10.1258/td.2011.110247 DO - 10.1258/td.2011.110247 ID - Mishra2012 ER - TY - JOUR AU - Chisompola, N. K. AU - Streicher, E. M. AU - Muchemwa, C. M. K. AU - Warren, R. M. AU - Sampson, S. L. PY - 2020 DA - 2020// TI - Molecular epidemiology of drug resistant Mycobacterium tuberculosis in Africa: a systematic review JO - BMC Infect Dis VL - 20 UR - https://doi.org/10.1186/s12879-020-05031-5 DO - 10.1186/s12879-020-05031-5 ID - Chisompola2020 ER - TY - JOUR AU - Kigozi, G. AU - Heunis, C. AU - Chikobvu, P. AU - Botha, S. AU - Rensburg, D. PY - 2017 DA - 2017// TI - Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa, International journal of infectious diseases : IJID : official publication of the International Society for JO - Infect Dis VL - 54 ID - Kigozi2017 ER - TY - JOUR AU - Silva, M. R. AU - Pereira, J. C. AU - Costa, R. R. AU - Dias, J. A. AU - Guimaraes, M. D. C. AU - Leite, I. C. G. PY - 2017 DA - 2017// TI - Drug addiction and alcoholism as predictors for tuberculosis treatment default in Brazil: a prospective cohort study JO - Epidemiol Infect VL - 145 UR - https://doi.org/10.1017/S0950268817002631 DO - 10.1017/S0950268817002631 ID - Silva2017 ER - TY - STD TI - Priedeman Skiles M, Curtis SL, Angeles G, Mullen S, Senik T, Evaluating the impact of social support services on tuberculosis treatment default in Ukraine, PloS One, 13 (2018) e0199513. ID - ref33 ER - TY - JOUR AU - Lackey, B. AU - Seas, C. AU - Stuyft, P. AU - Otero, L. PY - 2015 DA - 2015// TI - Patient characteristics associated with tuberculosis treatment default: a cohort study in a high-incidence area of lima JO - Peru PloS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0128541 DO - 10.1371/journal.pone.0128541 ID - Lackey2015 ER - TY - JOUR AU - Li, X. AU - Zhang, H. AU - Jiang, S. PY - 2010 DA - 2010// TI - Active pulmonary tuberculosis case detection and treatment among floating population in China: an effective pilot JO - J Immigr Minor Health VL - 12 UR - https://doi.org/10.1007/s10903-010-9336-6 DO - 10.1007/s10903-010-9336-6 ID - Li2010 ER - TY - JOUR AU - Li, X. AU - Li, T. AU - Tan, S. PY - 2013 DA - 2013// TI - Males, ages >/= 45 years, businessperson, floating population, and rural residents may be considered high-risk groups for tuberculosis infection in Guangzhou, China: a review of 136,394 tb confirmed cases JO - Rev Inst Med Trop Sao Paulo VL - 55 UR - https://doi.org/10.1590/S0036-46652013000500013 DO - 10.1590/S0036-46652013000500013 ID - Li2013 ER -